The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia

Abstract Background We previously identified the c.344G > A: p.(Arg115His) variant in the low-density lipoprotein receptor (LDLR) gene, which was interpreted as “conflicting interpretations of pathogenicity” in ClinVar, based on a genetic analysis of patients with familial hypercholesterolemia (F...

Full description

Bibliographic Details
Main Authors: Mika Hori, Atsushi Takahashi, Cheol Son, Masatsune Ogura, Mariko Harada-Shiba
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12944-020-01252-4
id doaj-f882df5c9c6e461db4b0df137fb7393b
record_format Article
spelling doaj-f882df5c9c6e461db4b0df137fb7393b2020-11-25T02:06:28ZengBMCLipids in Health and Disease1476-511X2020-04-011911510.1186/s12944-020-01252-4The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemiaMika Hori0Atsushi Takahashi1Cheol Son2Masatsune Ogura3Mariko Harada-Shiba4Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research InstituteDepartment of Genomic Medicine, National Cerebral and Cardiovascular Center Research InstituteLaboratory of Clinical Genetics, National Cerebral and Cardiovascular CenterDepartment of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research InstituteDepartment of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research InstituteAbstract Background We previously identified the c.344G > A: p.(Arg115His) variant in the low-density lipoprotein receptor (LDLR) gene, which was interpreted as “conflicting interpretations of pathogenicity” in ClinVar, based on a genetic analysis of patients with familial hypercholesterolemia (FH). However, whether this variant affects the pathophysiology of FH remains unclear. Therefore, our aim was to annotate the c.344G > A: p.(Arg115His) variant in the LDLR gene in FH. We present 2 families harboring the c.344G > A: p.(Arg115His) variant in the LDLR gene. Methods Genetic analyses were performed for the coding regions and the exon-intron boundary sequence of the LDLR and proprotein convertase subtilisin/kexin type 9 (PCSK9) genes in 2 FH families. Next, the family without pathogenic variants in the LDLR and PCSK9 genes was screened by whole-exome sequencing. Detailed clinical and biochemical data were gathered from family members. Results In one family, the index case had biallelic c.1567G > A: p.(Val523Met) and c.344G > A: p.(Arg115His) variants in the LDLR gene, while the sibling had only the c.1567G > A: p.(Val523Met) variant in the LDLR gene. There was no difference in the FH phenotype between the siblings. In another family, the index case and the sibling had no pathogenic variants in the LDLR, PCSK9, and apolipoprotein B (APOB) genes, but the sibling’s wife with nonFH had the c.344G > A: p.(Arg115His) variant in the LDLR gene. The sibling and his wife had 4 children, including an unaffected child and an affected child who had the c.344G > A: p.(Arg115His) variant in the LDLR gene. In addition, the allele frequency of the c.344G > A: p.(Arg115His) variant (0.0023–0.0043) in Japanese and East Asian populations is relatively high compared with that of the other LDLR pathogenic variants (0.0001–0.0008). Conclusions The c.344G > A: p.(Arg115His) variant in the LDLR gene is interpreted as benign in individuals with FH.http://link.springer.com/article/10.1186/s12944-020-01252-4LDL receptorFamilial hypercholesterolemiaVariantBenignAnnotation
collection DOAJ
language English
format Article
sources DOAJ
author Mika Hori
Atsushi Takahashi
Cheol Son
Masatsune Ogura
Mariko Harada-Shiba
spellingShingle Mika Hori
Atsushi Takahashi
Cheol Son
Masatsune Ogura
Mariko Harada-Shiba
The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia
Lipids in Health and Disease
LDL receptor
Familial hypercholesterolemia
Variant
Benign
Annotation
author_facet Mika Hori
Atsushi Takahashi
Cheol Son
Masatsune Ogura
Mariko Harada-Shiba
author_sort Mika Hori
title The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia
title_short The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia
title_full The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia
title_fullStr The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia
title_full_unstemmed The benign c.344G > A: p.(Arg115His) variant in the LDLR gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia
title_sort benign c.344g > a: p.(arg115his) variant in the ldlr gene interpreted from a pedigree-based genetic analysis of familial hypercholesterolemia
publisher BMC
series Lipids in Health and Disease
issn 1476-511X
publishDate 2020-04-01
description Abstract Background We previously identified the c.344G > A: p.(Arg115His) variant in the low-density lipoprotein receptor (LDLR) gene, which was interpreted as “conflicting interpretations of pathogenicity” in ClinVar, based on a genetic analysis of patients with familial hypercholesterolemia (FH). However, whether this variant affects the pathophysiology of FH remains unclear. Therefore, our aim was to annotate the c.344G > A: p.(Arg115His) variant in the LDLR gene in FH. We present 2 families harboring the c.344G > A: p.(Arg115His) variant in the LDLR gene. Methods Genetic analyses were performed for the coding regions and the exon-intron boundary sequence of the LDLR and proprotein convertase subtilisin/kexin type 9 (PCSK9) genes in 2 FH families. Next, the family without pathogenic variants in the LDLR and PCSK9 genes was screened by whole-exome sequencing. Detailed clinical and biochemical data were gathered from family members. Results In one family, the index case had biallelic c.1567G > A: p.(Val523Met) and c.344G > A: p.(Arg115His) variants in the LDLR gene, while the sibling had only the c.1567G > A: p.(Val523Met) variant in the LDLR gene. There was no difference in the FH phenotype between the siblings. In another family, the index case and the sibling had no pathogenic variants in the LDLR, PCSK9, and apolipoprotein B (APOB) genes, but the sibling’s wife with nonFH had the c.344G > A: p.(Arg115His) variant in the LDLR gene. The sibling and his wife had 4 children, including an unaffected child and an affected child who had the c.344G > A: p.(Arg115His) variant in the LDLR gene. In addition, the allele frequency of the c.344G > A: p.(Arg115His) variant (0.0023–0.0043) in Japanese and East Asian populations is relatively high compared with that of the other LDLR pathogenic variants (0.0001–0.0008). Conclusions The c.344G > A: p.(Arg115His) variant in the LDLR gene is interpreted as benign in individuals with FH.
topic LDL receptor
Familial hypercholesterolemia
Variant
Benign
Annotation
url http://link.springer.com/article/10.1186/s12944-020-01252-4
work_keys_str_mv AT mikahori thebenignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia
AT atsushitakahashi thebenignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia
AT cheolson thebenignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia
AT masatsuneogura thebenignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia
AT marikoharadashiba thebenignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia
AT mikahori benignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia
AT atsushitakahashi benignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia
AT cheolson benignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia
AT masatsuneogura benignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia
AT marikoharadashiba benignc344gaparg115hisvariantintheldlrgeneinterpretedfromapedigreebasedgeneticanalysisoffamilialhypercholesterolemia
_version_ 1724933800379547648